Human Toxicology Project Consortium

Human Toxicology Project Consortium

Advancing a new paradigm for assessing chemical safety

  • Home
  • The Project
    • Advancing the Science
      • Publications
      • Presentations
      • Sponsored Events & Projects
    • Communicating the Vision
    • Advocacy
  • The Consortium
  • Systems Toxicology 101
    • What is Toxicology?
    • Current Approaches to Chemical Evaluation
    • Limitations of the Current Testing Approach
    • Pathway-based Toxicology
    • Video Series: Pathways to a Better Future
  • About “Pathways”
    • AOPs 101
    • AOPs 201
    • AOP Online Course
  • Latest News
  • Resources
    • Informational videos
    • Background Readings
    • Web sites of interest
  • BioMed21
  • Risk Assessment

  • Stem cells grown from human skin used to study fatty liver disease

    Fatty liver disease affects hundreds of millions of people worldwide, but studying animals in the lab does not allow us to fully understand this uniquely... Read More

  • Move over monkeys: Understanding viral infections without using animals

    Mosquito-borne viruses such as Zika and dengue are often studied using monkeys, mice and other animals, even though vaccines shown to protect monkeys from infection... Read More

  • Early-career scientists awarded HTPC travel grants to attend JRC summer school on non-animal approaches

    We are thrilled to announce financial support enabling three promising early career researchers to attend the European Commission’s Joint Research Centre (JRC) Summer School May... Read More

  • Unilever & Humane Society International join forces to end cosmetics animal testing

    Human Toxicology Project Consortium founding members Unilever and Humane Society International (HSI) have teamed up to eliminate animal testing in the global cosmetics industry within... Read More
The Human Toxicology Project Consortium is a group of stakeholders from corporate and public interest communities that share the goal of advancing a biological pathway-based approach to toxicology, as described in the National Research Council's 2007 report, "Toxicity Testing in the 21st Century." The Consortium works to increase financial support and incentives to advance the science and technology behind pathway-based toxicology, and works to facilitate public and regulatory acceptance of predominantly in vitro and in silico toxicity testing.

HTPC Tweets

  • RT @BioMed_21: Early Career Researchers #ECR with an interest in #Diabetes or #Ageing - why not apply for a Hillblom Foundation Start-Up Gr… 11 minutes ago
  • There’s still time to register for the next Gordon Research Conference on Environmental Endocrine Disruptors schedu… twitter.com/i/web/status/1… 1 day ago
Follow @HumanToxProject

Recent Posts

  • Stem cells grown from human skin used to study fatty liver disease
  • Move over monkeys: Understanding viral infections without using animals
  • Early-career scientists awarded HTPC travel grants to attend JRC summer school on non-animal approaches

Enter your email address to follow this blog and receive notifications of new posts by email.

Blog at WordPress.com.